News Releases 2012

RSS

25 DEC 2012 Pharmaceuticals
L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms approved for Carnitine Deficiency
25 DEC 2012 Pharmaceuticals
The World’s Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson’s Disease and Restless Legs Syndrome
25 DEC 2012 Pharmaceuticals
Otsuka and Lundbeck initiate the regulatory process for aripiprazole (once-monthly) depot formulation in Europe
20 NOV 2012 Nutraceuticals
Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceutical Will Continue to Support Safe Running and Encourage Runners to Complete the Full Distance
6 NOV 2012 Pharmaceuticals
Otsuka Pharmaceutical and Abdi İbrahim Established a Joint Venture Company for Pharmaceutical Sales in Turkey
5 NOV 2012 Corporate
Otsuka Pharmaceutical Tokushima Itano Factory to Cosponsor Asan Walking Festival in Itano
A Portion of Entry Fees to be Donated to Great East Japan Earthquake Relief Efforts
5 NOV 2012 Pharmaceuticals
Otsuka’s Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
29 OCT 2012 Nutraceuticals
Kenja no Shokutaku Double Support
Food for Specified Health Use with Dual Function Suppressing the Absorption of Both Sugars and Lipids, to Launch in Japan for the First Time
1 OCT 2012 Nutraceuticals
Super Vitamin D, Containing the Daily Optimum Dose of Vitamin D in One Single Tablet Launched from Nature Made® - America’s Number One Dietary Supplement Brand

Go to the Top

24 SEP 2012 Nutraceuticals
New “Poppy Seed & Lemon” from Gerble to launch on October 15
The No.1 French Health Food Brand now in 3,000 stores nationwide
14 SEP 2012 Pharmaceuticals
Kyowa Hakko Kirin Returns to Otsuka Pharmaceutical the Rights to Develop and Market Busulfex®, for Use As a Part of Conditioning Regimen Prior to Hematopoietic Progenitor Cell Transplantation, in Japan and in Asian Countries & Regions
3 SEP 2012 Pharmaceuticals
ABILIFY® ,The First Antipsychotic Agent in Japan
Applying for Adjunctive Treatment in Major Depressive Disorder
29 AUG 2012 Corporate
Otsuka, the First Pharmaceutical Company in Japan to Have Been Certified for “ISO22301”, the International Standard for Business Continuity Management
1 AUG 2012 Pharmaceuticals
Vasopressin V2-Receptor Antagonist, Samsca® Tablets were filed Additional Indication of the Treatment of Fluid Retention Associated with Cirrhosis of the Liver
1 AUG 2012 Nutraceuticals
Pocari Sweat Launches in Vietnam through New Joint Venture Company.
Vietnam Launch is the17th Market in the World Where the Pocari Sweat is Sold
30 JUL 2012 Corporate
Otsuka Pharmaceutical × Nakacho, Tokushima Prefecture Largest Free Live Music Concert in Japan to Be Held
19 JUL 2012 Pharmaceuticals
Acucela and Otsuka Pharmaceutical Announce the Initiation of a Phase 3 Clinical Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients with Dry Eye Syndrome
19 JUL 2012 Nutraceuticals
Otsuka Pharmaceutical To Boost Production Capacity and Increase Sales with Third Pocari Sweat Plant in Guandong Province,China
6 JUL 2012 Pharmaceuticals
Proteus Digital Health, Inc. and Otsuka Pharmaceutical Co., Ltd. Announce Worldwide Agreement to Develop Novel Digital Health Products

Go to the Top

Go to the Top